Please enable JavaScript to continue using this application.

Compare $BCAX vs $MNKD | Chartloom

Compare

$BCAX vs $MNKD

Bicara Therapeutics Inc · MannKind Corp

BCAX

Bicara Therapeutics Inc

MNKD

MannKind Corp

Compare $BCAX vs $MNKD

Comparing Bicara Therapeutics Inc and MannKind Corp

BCAXBicara Therapeutics Inc

MNKDMannKind Corp

BCAXBicara Therapeutics Inc

Market cap

$1.15B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

6.8%

52W performance

-2.8%

FCF yield

-11.8%

MNKDMannKind Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.01x

Rev growth (TTM)

30.5%

YTD performance

-41.3%

52W performance

-39.5%

FCF yield

-1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAX

MNKD

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

MNKD

MannKind Corp

Market Cap

BCAX$1.15B

MNKD$1.05B

Enterprise Value

BCAX$1.05B

MNKD$1.57B

Price

BCAX$17.50

MNKD$3.29

P/E Ratio

BCAXN/A

MNKDN/A

P/S Ratio

BCAX0.00x

MNKD2.67x

EV/Sales

BCAX0.00x

MNKD3.98x

EV/EBITDA

BCAX0.00x

MNKD43.92x

P/B Ratio

BCAX2.49x

MNKD69.42x

P/FCF Ratio

BCAXN/A

MNKDN/A

EV/FCF

BCAX-7.79x

MNKD-86.45x

PEG Ratio

BCAXN/A

MNKDN/A

Forward P/E (NTM)

BCAXN/A

MNKDN/A

Forward P/S (NTM)

BCAXN/A

MNKD2.01x

Revenue (TTM)

BCAX$0

MNKD$394M

Revenue Growth (YoY)

BCAXN/A

MNKD30.5%

Forward Rev Growth

BCAX1358.6%

MNKD13.7%

Gross Margin (TTM)

BCAX0.0%

MNKD76.8%

Operating Margin (TTM)

BCAX0.0%

MNKD2.3%

EBITDA Margin (TTM)

BCAX0.0%

MNKD8.7%

Net Margin (TTM)

BCAX0.0%

MNKD-10.9%

FCF Margin (TTM)

BCAXN/A

MNKD-4.6%

Net Income (TTM)

BCAX$-185M

MNKD$-43M

FCF (TTM)

BCAX$-135M

MNKD$-18M

EPS (TTM)

BCAX-$2.73

MNKD-$0.14

ROE (TTM)

BCAX-4149.0%

MNKD-29771.0%

ROA (TTM)

BCAX-3859.0%

MNKD-619.0%

ROIC (TTM)

BCAX-4149.0%

MNKD-2719.0%

Cash

BCAX$97M

MNKD$53M

Debt

BCAX$0

MNKD$570M

Net Cash/Debt

BCAX$97M

MNKD$-517M

Current Ratio (TTM)

BCAX11.59x

MNKD1.72x

Quick Ratio (TTM)

BCAX11.44x

MNKD1.29x

Debt/Equity (TTM)

BCAX0.00x

MNKD9.95x

Debt/Assets (TTM)

BCAX0.0%

MNKD0.0%

Interest Coverage (TTM)

BCAXN/A

MNKDN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

MNKD0.00x

Beta

BCAX0.94

MNKD1.09

52W Performance

BCAX-2.8%

MNKD-39.5%

YTD Performance

BCAX6.8%

MNKD-41.3%

% from 52W High

BCAX-43.5%

MNKD-49.5%

% from 52W Low

BCAX27.7%

MNKD47.5%

Asset Turnover (TTM)

BCAX0.00x

MNKD0.57x

FCF Yield (TTM)

BCAX-11.8%

MNKD-1.7%

Earnings Yield (TTM)

BCAX-16.1%

MNKD-4.1%

Dividend Yield (TTM)

BCAXN/A

MNKDN/A

Rule of 40

BCAX0.0

MNKD25.8

EV/GP/RG

BCAXN/A

MNKD0.15

Ticker research

View BCAX research View MNKD research

Metric	BCAX Bicara Therapeutics Inc	MNKD MannKind Corp
Market & Valuation
Market Cap	$1.15B	$1.05B
Enterprise Value	$1.05B	$1.57B
Price	$17.50	$3.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.67x
EV/Sales	0.00x	3.98x
EV/EBITDA	0.00x	43.92x
P/B Ratio	2.49x	69.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-86.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.01x
Revenue & Growth
Revenue (TTM)	$0	$394M
Revenue Growth (YoY)	N/A	30.5%
Forward Rev Growth	1358.6%	13.7%
Profitability
Gross Margin (TTM)	0.0%	76.8%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	0.0%	8.7%
Net Margin (TTM)	0.0%	-10.9%
FCF Margin (TTM)	N/A	-4.6%
Net Income (TTM)	$-185M	$-43M
FCF (TTM)	$-135M	$-18M
EPS (TTM)	-$2.73	-$0.14
ROE (TTM)	-4149.0%	-29771.0%
ROA (TTM)	-3859.0%	-619.0%
ROIC (TTM)	-4149.0%	-2719.0%
Financial Health
Cash	$97M	$53M
Debt	$0	$570M
Net Cash/Debt	$97M	$-517M
Current Ratio (TTM)	11.59x	1.72x
Quick Ratio (TTM)	11.44x	1.29x
Debt/Equity (TTM)	0.00x	9.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	1.09
52W Performance	-2.8%	-39.5%
YTD Performance	6.8%	-41.3%
% from 52W High	-43.5%	-49.5%
% from 52W Low	27.7%	47.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.57x
FCF Yield (TTM)	-11.8%	-1.7%
Earnings Yield (TTM)	-16.1%	-4.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	25.8
EV/GP/RG	N/A	0.15
Ticker research	View BCAX research	View MNKD research

Valuation

P/S Ratio

BCAX

0.00x

MNKD

2.67x

EV/FCF

MNKD

-86.45x

BCAX

-7.79x

Growth & revenue

Revenue Growth TTM

MNKD

30.5%

Forward Revenue Growth

BCAX

1358.6%

MNKD

13.7%

Profitability & performance

Gross Margin

MNKD

76.8%

BCAX

0.0%

ROE

BCAX

-4149.0%

MNKD

-29771.0%

FCF Yield %

MNKD

-1.7%

BCAX

-11.8%

52-Week Performance

BCAX

-2.8%

MNKD

-39.5%

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

MNKD

MannKind Corp

Market Cap

BCAX$1.15B

MNKD$1.05B

Enterprise Value

BCAX$1.05B

MNKD$1.57B

Price

BCAX$17.50

MNKD$3.29

P/E Ratio

BCAXN/A

MNKDN/A

P/S Ratio

BCAX0.00x

MNKD2.67x

EV/Sales

BCAX0.00x

MNKD3.98x

EV/EBITDA

BCAX0.00x

MNKD43.92x

P/B Ratio

BCAX2.49x

MNKD69.42x

P/FCF Ratio

BCAXN/A

MNKDN/A

EV/FCF

BCAX-7.79x

MNKD-86.45x

PEG Ratio

BCAXN/A

MNKDN/A

Forward P/E (NTM)

BCAXN/A

MNKDN/A

Forward P/S (NTM)

BCAXN/A

MNKD2.01x

Revenue (TTM)

BCAX$0

MNKD$394M

Revenue Growth (YoY)

BCAXN/A

MNKD30.5%

Forward Rev Growth

BCAX1358.6%

MNKD13.7%

Gross Margin (TTM)

BCAX0.0%

MNKD76.8%

Operating Margin (TTM)

BCAX0.0%

MNKD2.3%

EBITDA Margin (TTM)

BCAX0.0%

MNKD8.7%

Net Margin (TTM)

BCAX0.0%

MNKD-10.9%

FCF Margin (TTM)

BCAXN/A

MNKD-4.6%

Net Income (TTM)

BCAX$-185M

MNKD$-43M

FCF (TTM)

BCAX$-135M

MNKD$-18M

EPS (TTM)

BCAX-$2.73

MNKD-$0.14

ROE (TTM)

BCAX-4149.0%

MNKD-29771.0%

ROA (TTM)

BCAX-3859.0%

MNKD-619.0%

ROIC (TTM)

BCAX-4149.0%

MNKD-2719.0%

Cash

BCAX$97M

MNKD$53M

Debt

BCAX$0

MNKD$570M

Net Cash/Debt

BCAX$97M

MNKD$-517M

Current Ratio (TTM)

BCAX11.59x

MNKD1.72x

Quick Ratio (TTM)

BCAX11.44x

MNKD1.29x

Debt/Equity (TTM)

BCAX0.00x

MNKD9.95x

Debt/Assets (TTM)

BCAX0.0%

MNKD0.0%

Interest Coverage (TTM)

BCAXN/A

MNKDN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

MNKD0.00x

Beta

BCAX0.94

MNKD1.09

52W Performance

BCAX-2.8%

MNKD-39.5%

YTD Performance

BCAX6.8%

MNKD-41.3%

% from 52W High

BCAX-43.5%

MNKD-49.5%

% from 52W Low

BCAX27.7%

MNKD47.5%

Asset Turnover (TTM)

BCAX0.00x

MNKD0.57x

FCF Yield (TTM)

BCAX-11.8%

MNKD-1.7%

Earnings Yield (TTM)

BCAX-16.1%

MNKD-4.1%

Dividend Yield (TTM)

BCAXN/A

MNKDN/A

Rule of 40

BCAX0.0

MNKD25.8

EV/GP/RG

BCAXN/A

MNKD0.15

Ticker research

View BCAX research View MNKD research

Metric	BCAX Bicara Therapeutics Inc	MNKD MannKind Corp
Market & Valuation
Market Cap	$1.15B	$1.05B
Enterprise Value	$1.05B	$1.57B
Price	$17.50	$3.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.67x
EV/Sales	0.00x	3.98x
EV/EBITDA	0.00x	43.92x
P/B Ratio	2.49x	69.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-86.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.01x
Revenue & Growth
Revenue (TTM)	$0	$394M
Revenue Growth (YoY)	N/A	30.5%
Forward Rev Growth	1358.6%	13.7%
Profitability
Gross Margin (TTM)	0.0%	76.8%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	0.0%	8.7%
Net Margin (TTM)	0.0%	-10.9%
FCF Margin (TTM)	N/A	-4.6%
Net Income (TTM)	$-185M	$-43M
FCF (TTM)	$-135M	$-18M
EPS (TTM)	-$2.73	-$0.14
ROE (TTM)	-4149.0%	-29771.0%
ROA (TTM)	-3859.0%	-619.0%
ROIC (TTM)	-4149.0%	-2719.0%
Financial Health
Cash	$97M	$53M
Debt	$0	$570M
Net Cash/Debt	$97M	$-517M
Current Ratio (TTM)	11.59x	1.72x
Quick Ratio (TTM)	11.44x	1.29x
Debt/Equity (TTM)	0.00x	9.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	1.09
52W Performance	-2.8%	-39.5%
YTD Performance	6.8%	-41.3%
% from 52W High	-43.5%	-49.5%
% from 52W Low	27.7%	47.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.57x
FCF Yield (TTM)	-11.8%	-1.7%
Earnings Yield (TTM)	-16.1%	-4.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	25.8
EV/GP/RG	N/A	0.15
Ticker research	View BCAX research	View MNKD research